Advanced Biomed Inc.
ADVB
$0.42
$0.001.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.22% | 27.07% | -4.04% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.39% | 18.86% | -12.01% | -- | -- |
| Operating Income | -15.39% | -18.86% | 12.01% | -- | -- |
| Income Before Tax | -48.49% | -17.14% | 7.84% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -48.49% | -17.14% | 7.84% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.49% | -17.14% | 7.84% | -- | -- |
| EBIT | -15.39% | -18.86% | 12.01% | -- | -- |
| EBITDA | -23.84% | -24.99% | 19.38% | -- | -- |
| EPS Basic | -43.37% | -14.01% | 8.90% | -- | -- |
| Normalized Basic EPS | -43.60% | -14.15% | 8.92% | -- | -- |
| EPS Diluted | -43.37% | -14.01% | 8.90% | -- | -- |
| Normalized Diluted EPS | -43.60% | -14.15% | 8.92% | -- | -- |
| Average Basic Shares Outstanding | 4.69% | 2.64% | 0.71% | -- | -- |
| Average Diluted Shares Outstanding | 4.69% | 2.64% | 0.71% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |